Extramedullary NK-T-cell Lymphoma, Nasal Type
1 clinical trials · Condition
◉ Watch Extramedullary NK-T-cell Lymphoma, Nasal Type
| Record | Firm | Date |
|---|---|---|
| CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study (NCT04480788) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2020-11-24 |
Track Extramedullary NK-T-cell Lymphoma, Nasal Type automatically
Every clearance here is in the API, with alerts when new ones post.